Active Ingredient History
Alseroxylon is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Hypertension (approved 1953)
Atrial Fibrillation (Phase 4)
Brugada Syndrome (Phase 4)
Cardiovascular Diseases (Phase 3)
Death, Sudden (Phase 2)
Heart Diseases (Phase 3)
Hypertension (Phase 3)
Tachycardia, Ventricular (Phase 4)
Vascular Diseases (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue